Literature DB >> 24605310

PET Scan in Head and Neck Tumours in a Developing Country Like India: Is It a Must?

Neeti Madan Kapre1, Jyoti Pralhad Dabholkar2.   

Abstract

To study the impact of Positron emission tomography (PET) and its incremental value in diagnosing an unknown primary tumour with secondaries in the head and neck; recurrent head and neck cancers (confirmation of suspected recurrences and re-staging); and staging of head and neck tumours. This was a prospective observational study where 60 patients of head and neck tumours under the clinical settings as described above were evaluated. Thorough clinical examination and necessary radiological and histopathological investigations were done. All patients underwent a PET scan, the results of which were correlated with histopathological examination. Sensitivities, specificities, positive and negative predictive values, false positives and false negatives of PET scan in the different indications were calculated. The study included 11 patients of unknown primary, 28 patients with suspected recurrent tumours and 21 patients where PET scan was done for initial staging. PETCT scan was able to detect the primary in 3 out of 11 patients (27.27 %) who presented with cervical metastases with an unknown primary. In 2 of the 8 patients where a primary tumour was not found, PETCT detected distant metastases. For recurrent tumours, PETCT scan showed sensitivity, specificity, positive predictive value and negative predictive value as 100, 72.72, 85 and 100 % respectively. In restaging of recurrent disease, 4 out of 28 patients were detected to have distant metastases. In 7 cases of locoregionally advanced tumors, where PETCT scan was used for pre-treatment staging, it detected distant metastases in 4 of 7 patients. In the patients with N0 neck status PETCT scan showed a sensitivity, specificity, positive predictive value and negative predictive value of 100, 66.67, 50 and 100 % respectively. PETCT scan was able to alter the plan of management in 15 out of 60 patients. Thus, in carefully selected patients PETCT scan can provide incremental information that proves invaluable in these circumstances even in a developing country like India. In all the settings, PETCT scan demonstrated a very high negative predictive value. Hence, negative PETCT scan could be interpreted as absence of disease with reasonable assurance.

Entities:  

Keywords:  PETCT scan; Recurrent head and neck tumour; Unknown primary tumour

Year:  2013        PMID: 24605310      PMCID: PMC3938700          DOI: 10.1007/s12070-013-0691-1

Source DB:  PubMed          Journal:  Indian J Otolaryngol Head Neck Surg        ISSN: 2231-3796


  8 in total

1.  Surveillance for recurrent head and neck cancer using positron emission tomography.

Authors:  V J Lowe; J H Boyd; F R Dunphy; H Kim; T Dunleavy; B T Collins; D Martin; B C Stack; C Hollenbeak; J W Fletcher
Journal:  J Clin Oncol       Date:  2000-02       Impact factor: 44.544

2.  18F-FDG PET/CT for detecting nodal metastases in patients with oral cancer staged N0 by clinical examination and CT/MRI.

Authors:  Heiko Schöder; Diane L Carlson; Dennis H Kraus; Hilda E Stambuk; Mithat Gönen; Yusuf E Erdi; Henry W D Yeung; Andrew G Huvos; Jatin P Shah; Steven M Larson; Richard J Wong
Journal:  J Nucl Med       Date:  2006-05       Impact factor: 10.057

3.  The value of (18)F-FDG PET/CT for the detection of distant metastases in high-risk patients with head and neck squamous cell carcinoma.

Authors:  Stephan K Haerle; D T Schmid; N Ahmad; T F Hany; S J Stoeckli
Journal:  Oral Oncol       Date:  2011-06-11       Impact factor: 5.337

4.  Carcinoma of unknown primary in the head and neck: comparison between positron emission tomography (PET) and PET/CT.

Authors:  Florian Keller; Georgios Psychogios; Rainer Linke; Michael Lell; Torsten Kuwert; Heinrich Iro; Johannes Zenk
Journal:  Head Neck       Date:  2010-12-15       Impact factor: 3.147

Review 5.  The role of fluorodeoxyglucose positron emission tomography in cervical lymph node metastases from an unknown primary tumor.

Authors:  Kyle E Rusthoven; Mary Koshy; Arnold C Paulino
Journal:  Cancer       Date:  2004-12-01       Impact factor: 6.860

6.  Positron emission tomography with [18F]fluorodeoxyglucose improves staging and patient management in patients with head and neck squamous cell carcinoma: a multicenter prospective study.

Authors:  Max Lonneux; Marc Hamoir; Hervé Reychler; Philippe Maingon; Christian Duvillard; Gilles Calais; Boumédiène Bridji; Laurence Digue; Michel Toubeau; Vincent Grégoire
Journal:  J Clin Oncol       Date:  2010-02-01       Impact factor: 44.544

7.  PET-CT in recurrent head neck cancers: a study to evaluate impact on patient management.

Authors:  G H Pantvaidya; J P Agarwal; M S Deshpande; V Rangarajan; V Singh; A Kakade; A K D'Cruz
Journal:  J Surg Oncol       Date:  2009-10-01       Impact factor: 3.454

8.  Out-of-pocket healthcare payments on chronic conditions impoverish urban poor in Bangalore, India.

Authors:  Upendra Bhojani; Bs Thriveni; Roopa Devadasan; Cm Munegowda; Narayanan Devadasan; Patrick Kolsteren; Bart Criel
Journal:  BMC Public Health       Date:  2012-11-16       Impact factor: 3.295

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.